
After his cousin's leukemia diagnosis, Turner co-founded Flatiron Health, built the largest real-world oncology dataset in the U.S., and sold the company to Roche for $1.9 billion — accelerating cancer drug development in the process.
Nat Turner is the CEO and Chairman of Collectors, the collectibles authentication and grading company behind PSA and other brands.
He previously co-founded Flatiron Health in 2012, building it into the largest real-world oncology data platform in the United States before its $1.9 billion acquisition by Roche in 2018, and earlier co-founded Invite Media, acquired by Google.

An invitation, extended to Powered readers.